Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Genomics & Proteomics
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Cancer Genomics & Proteomics

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

tumor marker

  • Open Access
    Prognostic Significance of Transient Receptor Potential Vanilloid Type 1 (TRPV1) and Phosphatase and Tension Homolog (PTEN) in Epithelial Ovarian Cancer
    GWAN HEE HAN, DOO BYUNG CHAY, SANGHEE NAM, HANBYOUL CHO, JOON-YONG CHUNG and JAE-HOON KIM
    Cancer Genomics & Proteomics May 2020, 17 (3) 309-319; DOI: https://doi.org/10.21873/cgp.20191
  • Open Access
    Loss of Both USP10 and p14ARF Protein Expression Is an Independent Prognostic Biomarker for Poor Prognosis in Patients With Epithelial Ovarian Cancer
    GWAN HEE HAN, DOO BYUNG CHAY, JOO MI YI, HANBYOUL CHO, JOON-YONG CHUNG and JAE-HOON KIM
    Cancer Genomics & Proteomics November 2019, 16 (6) 553-562; DOI: https://doi.org/10.21873/cgp.20157
Cancer & Genome Proteomics

© 2023 Cancer Genomics & Proteomics

Powered by HighWire